+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alzheimer's Disease Treatment Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 89 Pages
  • November 2024
  • Region: Global
  • Prof Research
  • ID: 5726490
Description Jump to:
The Alzheimers Disease Treatment Market has been experiencing significant growth due to the increasing prevalence of Alzheimers disease, ongoing research and development activities, and the rising demand for effective treatments. As of 2023, it is anticipated that the market will reach a value of approximately $10.4 billion and is expected to grow significantly, with a compound annual growth rate (CAGR) of around 7.5% through the period of 2024-2029. This review provides an overview of the market dynamics, key players, product types, and trends that shape the future of the Alzheimers disease treatment landscape.

Market Overview

Alzheimers disease is a progressive neurodegenerative disorder that affects millions of individuals worldwide. The increasing global aging population and rising awareness regarding Alzheimers disease have driven demand for innovative therapies aimed at slowing disease progression or alleviating symptoms.

Market Size & Share

The Alzheimers Disease Treatment Market size is projected to reach approximately $19.5 billion by 2029. The market is characterized by the following segmentation:

  • Product Type: The market can be segmented into Aducanumab, Donanemab, Elayta, and others.
  • Key Players: Major players include Biogen, Eli Lilly, Cognition Therapeutics, Anavex Life Sciences, and Jupiter Neurosciences.
  • Region: The market is analyzed regionally, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Trends Analysis By Product Type

In terms of product type, the following drugs dominate the market:

  • Aducanumab: As the first drug approved under the accelerated approval pathway by the FDA in June 2021, Aducanumab has captured a significant share of the market. Its unique mechanism of targeting amyloid plaques offers a novel approach to treatment, leading to sales projections exceeding $5 billion by 2029.
  • Donanemab: Another promising monoclonal antibody that also targets amyloid-beta plaques. Eli Lilly's Donanemab is positioned for significant market impact, potentially generating revenues of $3 billion during this forecast period.
  • Elayta: Currently in various stages of clinical trials, Elayta shows potential to address tau pathology effectively, contributing to the growth of the Alzheimers treatment market.
  • Others: Other therapies, including symptomatic treatments and investigational drugs, also hold a considerable portion of the market share.

Analysis of Key Players

  • Biogen: A pioneer in the Alzheimers treatment space with Aducanumab, continuing to invest heavily in the research pipeline for therapies addressing neurodegenerative conditions.
  • Eli Lilly: Actively engaged with Donanemab and has a robust R&D portfolio aimed at Alzheimers innovations.
  • Cognition Therapeutics: Focused on novel mechanisms of action to treat Alzheimers, currently developing therapies aimed at synaptic health.
  • Anavex Life Sciences: Notably working on targeted gamma secretase modulators aimed at restoring cognitive function in Alzheimers patients.
  • Jupiter Neurosciences: Develops neuroprotective therapies using unique mechanisms to mitigate Alzheimer symptoms.

By Application & End-Use

The treatment applications for Alzheimers disease can be segregated into:

  • Clinical settings: Majority of treatments are administered in hospitals and specialized Alzheimers care centers.
  • Home care settings: Increased preference for home-based care, driven by easing management for caregivers.

Regional Analysis

The regional segmentation reveals interesting patterns:

  • North America: Account for the largest share, primarily due to the high prevalence of Alzheimers disease and availability of advanced healthcare. The market is projected to grow substantially in the coming years, with a forecasted value over $10 billion.
  • Europe: Following North America, Europe demonstrates significant market potential, with countries like Germany and the UK making substantial contributions.
  • Asia-Pacific: Fastest-growing region, driven by increasing aging population and healthcare improvements, with projected market growth up to $4 billion.
  • Latin America and MEA: Smaller markets but exhibit growing investments in healthcare infrastructure and increasing awareness.

Market News, Policy, and Companies

The landscape of Alzheimers disease treatment is influenced by regulatory policies and market dynamics:

  • FDA Approvals: The FDAs approval process, particularly for drugs like Aducanumab and Donanemab, shapes market accessibility and pricing.
  • Pharmaceutical Investments: Increased R&D investments targeting amyloid and tau research result in quicker development of effective therapies.
  • Healthcare Policies: Policies aimed at covering Alzheimers treatment under health insurance improve market accessibility for patients, enhancing demand.

Segment Forecasts 2024-2029

Looking forward, the Alzheimers Disease Treatment Market is poised for robust growth in several defined segments:

  • Product Type Growth: Aducanumab and Donanemab are expected to lead the market, with others gradually gaining traction as they complete clinical trials.
  • Regional Growth: The Asia-Pacific region will be the fastest-growing market, primarily due to demographic shifts and healthcare enhancements.
  • Application Development: Increased clinical and telehealth practices will enhance treatment delivery in both clinical and home settings.
In conclusion, the Alzheimers Disease Treatment Market is at a pivotal juncture, with innovative therapies entering the market and significant stakeholder investments reshaping the landscape. Firms engaging in R&D and adapting to policy changes will likely secure advantageous positions in this growing market through 2029.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Alzheimer’S Disease Treatment Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Alzheimer’S Disease Treatment Market in North America (2019-2029)
8.1 Alzheimer’S Disease Treatment Market Size
8.2 Alzheimer’S Disease Treatment Market by End Use
8.3 Competition by Players/Suppliers
8.4 Alzheimer’S Disease Treatment Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Alzheimer’S Disease Treatment Market in South America (2019-2029)
9.1 Alzheimer’S Disease Treatment Market Size
9.2 Alzheimer’S Disease Treatment Market by End Use
9.3 Competition by Players/Suppliers
9.4 Alzheimer’S Disease Treatment Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Alzheimer’S Disease Treatment Market in Asia & Pacific (2019-2029)
10.1 Alzheimer’S Disease Treatment Market Size
10.2 Alzheimer’S Disease Treatment Market by End Use
10.3 Competition by Players/Suppliers
10.4 Alzheimer’S Disease Treatment Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Alzheimer’S Disease Treatment Market in Europe (2019-2029)
11.1 Alzheimer’S Disease Treatment Market Size
11.2 Alzheimer’S Disease Treatment Market by End Use
11.3 Competition by Players/Suppliers
11.4 Alzheimer’S Disease Treatment Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Alzheimer’S Disease Treatment Market in MEA (2019-2029)
12.1 Alzheimer’S Disease Treatment Market Size
12.2 Alzheimer’S Disease Treatment Market by End Use
12.3 Competition by Players/Suppliers
12.4 Alzheimer’S Disease Treatment Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Alzheimer’S Disease Treatment Market (2019-2024)
13.1 Alzheimer’S Disease Treatment Market Size
13.2 Alzheimer’S Disease Treatment Market by End Use
13.3 Competition by Players/Suppliers
13.4 Alzheimer’S Disease Treatment Market Size by Type
Chapter 14 Global Alzheimer’S Disease Treatment Market Forecast (2024-2029)
14.1 Alzheimer’S Disease Treatment Market Size Forecast
14.2 Alzheimer’S Disease Treatment Application Forecast
14.3 Competition by Players/Suppliers
14.4 Alzheimer’S Disease Treatment Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Biogen
15.1.1 Company Profile
15.1.2 Main Business and Alzheimer’s Disease Treatment Information
15.1.3 SWOT Analysis of Biogen
15.1.4 Biogen Alzheimer’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.2 Eli Lilly
15.2.1 Company Profile
15.2.2 Main Business and Alzheimer’s Disease Treatment Information
15.2.3 SWOT Analysis of Eli Lilly
15.2.4 Eli Lilly Alzheimer’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.3 Cognition Therapeutics
15.3.1 Company Profile
15.3.2 Main Business and Alzheimer’s Disease Treatment Information
15.3.3 SWOT Analysis of Cognition Therapeutics
15.3.4 Cognition Therapeutics Alzheimer’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.4 Anavex Life Sciences
15.4.1 Company Profile
15.4.2 Main Business and Alzheimer’s Disease Treatment Information
15.4.3 SWOT Analysis of Anavex Life Sciences
15.4.4 Anavex Life Sciences Alzheimer’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.5 Jupiter Neurosciences
15.5.1 Company Profile
15.5.2 Main Business and Alzheimer’s Disease Treatment Information
15.5.3 SWOT Analysis of Jupiter Neurosciences
15.5.4 Jupiter Neurosciences Alzheimer’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Alzheimer’S Disease Treatment Report
Table Data Sources of Alzheimer’S Disease Treatment Report
Table Major Assumptions of Alzheimer’S Disease Treatment Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Alzheimer’S Disease Treatment Picture
Table Alzheimer’S Disease Treatment Classification
Table Alzheimer’S Disease Treatment Applications
Table Drivers of Alzheimer’S Disease Treatment Market
Table Restraints of Alzheimer’S Disease Treatment Market
Table Opportunities of Alzheimer’S Disease Treatment Market
Table Threats of Alzheimer’S Disease Treatment Market
Table COVID-19 Impact For Alzheimer’S Disease Treatment Market
Table Raw Materials Suppliers
Table Different Production Methods of Alzheimer’S Disease Treatment
Table Cost Structure Analysis of Alzheimer’S Disease Treatment
Table Key End Users
Table Latest News of Alzheimer’S Disease Treatment Market
Table Merger and Acquisition
Table Planned/Future Project of Alzheimer’S Disease Treatment Market
Table Policy of Alzheimer’S Disease Treatment Market
Table 2019-2029 North America Alzheimer’S Disease Treatment Market Size
Figure 2019-2029 North America Alzheimer’S Disease Treatment Market Size and CAGR
Table 2019-2029 North America Alzheimer’S Disease Treatment Market Size by Application
Table 2019-2024 North America Alzheimer’S Disease Treatment Key Players Revenue
Table 2019-2024 North America Alzheimer’S Disease Treatment Key Players Market Share
Table 2019-2029 North America Alzheimer’S Disease Treatment Market Size by Type
Table 2019-2029 United States Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Canada Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Mexico Alzheimer’S Disease Treatment Market Size
Table 2019-2029 South America Alzheimer’S Disease Treatment Market Size
Figure 2019-2029 South America Alzheimer’S Disease Treatment Market Size and CAGR
Table 2019-2029 South America Alzheimer’S Disease Treatment Market Size by Application
Table 2019-2024 South America Alzheimer’S Disease Treatment Key Players Revenue
Table 2019-2024 South America Alzheimer’S Disease Treatment Key Players Market Share
Table 2019-2029 South America Alzheimer’S Disease Treatment Market Size by Type
Table 2019-2029 Brazil Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Argentina Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Chile Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Peru Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Asia & Pacific Alzheimer’S Disease Treatment Market Size
Figure 2019-2029 Asia & Pacific Alzheimer’S Disease Treatment Market Size and CAGR
Table 2019-2029 Asia & Pacific Alzheimer’S Disease Treatment Market Size by Application
Table 2019-2024 Asia & Pacific Alzheimer’S Disease Treatment Key Players Revenue
Table 2019-2024 Asia & Pacific Alzheimer’S Disease Treatment Key Players Market Share
Table 2019-2029 Asia & Pacific Alzheimer’S Disease Treatment Market Size by Type
Table 2019-2029 China Alzheimer’S Disease Treatment Market Size
Table 2019-2029 India Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Japan Alzheimer’S Disease Treatment Market Size
Table 2019-2029 South Korea Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Southeast Asia Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Australia Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Europe Alzheimer’S Disease Treatment Market Size
Figure 2019-2029 Europe Alzheimer’S Disease Treatment Market Size and CAGR
Table 2019-2029 Europe Alzheimer’S Disease Treatment Market Size by Application
Table 2019-2024 Europe Alzheimer’S Disease Treatment Key Players Revenue
Table 2019-2024 Europe Alzheimer’S Disease Treatment Key Players Market Share
Table 2019-2029 Europe Alzheimer’S Disease Treatment Market Size by Type
Table 2019-2029 Germany Alzheimer’S Disease Treatment Market Size
Table 2019-2029 France Alzheimer’S Disease Treatment Market Size
Table 2019-2029 United Kingdom Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Italy Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Spain Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Belgium Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Netherlands Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Austria Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Poland Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Russia Alzheimer’S Disease Treatment Market Size
Table 2019-2029 MEA Alzheimer’S Disease Treatment Market Size
Figure 2019-2029 MEA Alzheimer’S Disease Treatment Market Size and CAGR
Table 2019-2029 MEA Alzheimer’S Disease Treatment Market Size by Application
Table 2019-2024 MEA Alzheimer’S Disease Treatment Key Players Revenue
Table 2019-2024 MEA Alzheimer’S Disease Treatment Key Players Market Share
Table 2019-2029 MEA Alzheimer’S Disease Treatment Market Size by Type
Table 2019-2029 Egypt Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Israel Alzheimer’S Disease Treatment Market Size
Table 2019-2029 South Africa Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Gulf Cooperation Council Countries Alzheimer’S Disease Treatment Market Size
Table 2019-2029 Turkey Alzheimer’S Disease Treatment Market Size
Table 2019-2024 Global Alzheimer’S Disease Treatment Market Size by Region
Table 2019-2024 Global Alzheimer’S Disease Treatment Market Size Share by Region
Table 2019-2024 Global Alzheimer’S Disease Treatment Market Size by Application
Table 2019-2024 Global Alzheimer’S Disease Treatment Market Share by Application
Table 2019-2024 Global Alzheimer’S Disease Treatment Key Vendors Revenue
Figure 2019-2024 Global Alzheimer’S Disease Treatment Market Size and Growth Rate
Table 2019-2024 Global Alzheimer’S Disease Treatment Key Vendors Market Share
Table 2019-2024 Global Alzheimer’S Disease Treatment Market Size by Type
Table 2019-2024 Global Alzheimer’S Disease Treatment Market Share by Type
Table 2024-2029 Global Alzheimer’S Disease Treatment Market Size by Region
Table 2024-2029 Global Alzheimer’S Disease Treatment Market Size Share by Region
Table 2024-2029 Global Alzheimer’S Disease Treatment Market Size by Application
Table 2024-2029 Global Alzheimer’S Disease Treatment Market Share by Application
Table 2024-2029 Global Alzheimer’S Disease Treatment Key Vendors Revenue
Figure 2024-2029 Global Alzheimer’S Disease Treatment Market Size and Growth Rate
Table 2024-2029 Global Alzheimer’S Disease Treatment Key Vendors Market Share
Table 2024-2029 Global Alzheimer’S Disease Treatment Market Size by Type
Table 2024-2029 Alzheimer’S Disease Treatment Global Market Share by Type

Companies Mentioned

  • Biogen
  • Eli Lilly
  • Cognition Therapeutics
  • Anavex Life Sciences
  • Jupiter Neurosciences

Related Topics

Related Reports

Alzheimer's Disease Drugs Market by Drug Class, Distribution Channel - Global Forecast 2025-2030 - Product Image

Alzheimer's Disease Drugs Market by Drug Class, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Alzheimer's Disease Drugs - Global Strategic Business Report - Product Image

Alzheimer's Disease Drugs - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Alzheimer's Disease Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Alzheimer's Disease Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 314 Pages
  • Global
From
Alzheimer's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034 - Product Image

Alzheimer's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

  • Report
  • 140 Pages
  • Global
From
Alzheimer's Drugs Market Report by Drug Class, Drug Type, Distribution Channel, Region and Company Analysis 2024-2032 - Product Image

Alzheimer's Drugs Market Report by Drug Class, Drug Type, Distribution Channel, Region and Company Analysis 2024-2032

  • Report
  • 225 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.